Generic Name and Formulations:
Trivalent inactivated "split virus" influenza vaccine (Types A and B); formulation changes annually; susp for IM inj; contains thimerosal.
Novartis Pharmaceuticals Corp
Indications for FLUVIRIN:
Adults and Children:
<4yrs: not recommended. Each dose is 0.5mL IM. 4–8yrs: 2 doses at least 1 month apart for 1st immunization, otherwise 1 dose per season. >9yrs: 1 dose/season. Infants and young children: give in anterolateral thigh; older: give in deltoid muscle.
Allergy to egg proteins. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Have epinephrine inj (1:1000) available. Pregnancy (Cat.C). Nursing mothers.
Concomitant vaccines: insufficient data (see literature). Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids) may result in suboptimal response.
Local reactions, headache, fever, malaise, fatigue, myalgia.
Multidose vial (5mL)—1
Single-dose prefilled syringes (0.5mL)—10
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Breast Implant-Associated Anaplastic Large Cell Lymphoma — In the Clinic
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- 5α-Reductase Inhibitors Do Not Increase Risk of High-Grade Prostate Cancer
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy